January 2013，ABO Alliance member Beijing Zhaoyan New Pharmaceutical Research Center Co., Ltd. (hereinafter referred to as & ldquo; Zhaoyan Company & RDQUO;) acquired Bayer Pharmaceutical's R & D and production base in San Francisco, USA，Created the pioneer of Chinese biomedical companies to acquire the global R & D base of multinational companies overseas。
 
According to the reporter's understanding，Zhaoyan (Beijing) New Pharmaceutical Research Center Co., Ltd. is the earliest private stake online sports bettingstake betting appenterprise engaged in new pharmaceutical and pharmaceutical research，It is one of the eight members of the ABO Alliance。Established in August 1995, it has developed into a professional and technical team with nearly 400 people，It has become one of the largest institutions that have been engaged in drug clinical evaluation services in China，In 2012, the income exceeded 60 million yuan。
 
Future，Zhaoyan will rely on the base，Investment of $ 100 million & ldquo, which covers an area of ​​300 acres;，Provide enterprise incubation for Silicon Valley small and medium biomedical innovation enterprises、Technical support、International stake betting appstake online sports bettingcooperation and other services。